CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 target
Drug / intervention
Synbiotic (Synergy I / B.longum)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00305409
NCT00305409N/ACompleted
CompareCT.gov

Synbiotic Treatment in Crohn's Disease Patients

University of Dundee·interventional·Posted Mar 21, 2006·Updated Feb 11, 2009

In Brief

A clinical study evaluating Synbiotic (Synergy I / B.longum) for Crohn's Disease. Completed, enrolled 50 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether administration of a synbiotic, comprised on inulin and a bifidobacterial probiotic will colonise the gut wall and down-regulate TNF-alpha and other pro-inflammatory cytokines in the mucosa of Crohn's patients with active disease to reduce mucosal inflammation and induce remission.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn's Disease
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2006
Enrollment StartJun 1, 2006
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 20.3 years ago

Interventions

Synbiotic (Synergy I / B.longum)drug